Inventor · disambiguated record
Scott Eugene Conner
Also filed as: CONNER SCOTT E · CONNER SCOTT EUGENE
21 granted patents·6 pending applications·126 citations·filing 2001–2024
94Inventor score
Top patents by PatentIndex Score
27 records- 0193US7351728B2Oxazolyl-aryloxyacetic acid derivatives and their use as PPAR agonistsLILLY CO ELI·Filed 2005·Granted Apr 1, 2008·27 cites·4 claims
- 0286US7598266B2Fused heterocyclic derivatives as PPAR modulatorsLILLY CO ELI·Filed 2008·Granted Oct 6, 2009·8 cites·24 claims
- 0385US7816557B2Glucagon receptor antagonists, preparation and therapeutic usesLILLY CO ELI·Filed 2005·Granted Oct 19, 2010·6 cites·6 claims
- 0482US6982278B2Oxazolyl-aryloxyacetic acid derivatives and their use as ppar agonistsLILLY CO ELI·Filed 2001·Granted Jan 3, 2006·14 cites·32 claims
- 0581US6515013B21,3-disubstituted and 1,3,3-trisubstituted pyrrolidines as histamine-3 receptor ligands and their therapeutic applicationsABBOTT LAB·Filed 2001·Granted Feb 4, 2003·12 cites·15 claims
- 0680US7153878B2Peroxisome proliferator activated receptor modulatorsLILLY CO ELI·Filed 2003·Granted Dec 26, 2006·11 cites·25 claims
- 0779US7384965B2Fused heterocyclic derivatives as PPAR modulatorsLILLY CO ELI·Filed 2003·Granted Jun 10, 2008·10 cites·29 claims
- 0876US7696248B2Glucagon receptor antagonists, preparation and therapeutic usesLILLY CO ELI·Filed 2006·Granted Apr 13, 2010·3 cites·12 claims
- 0974US7259175B2Peroxisome proliferator activated receptor modulatorsLILLY CO ELI·Filed 2003·Granted Aug 21, 2007·7 cites·22 claims
- 1074US6620839B21,3-disubstituted and 1,3,3-trisubstituted pyrrolidines as histamine-3 receptor ligands and their therapeutic applicationsABBOTT LAB·Filed 2002·Granted Sep 16, 2003·11 cites·19 claims
- 1171US7989457B2Glucagon receptor antagonists, preparation and therapeutic usesLILLY CO ELI·Filed 2005·Granted Aug 2, 2011·2 cites·6 claims
- 1270US7655641B2Sulfonamide derivatives as PPAR modulatorsLILLY CO ELI·Filed 2004·Granted Feb 2, 2010·5 cites·19 claims
- 1369US7405305B2Pyrrole-2, 5dione derivatives and their used as GSK-3 inhibitorsLILLY CO ELI·Filed 2003·Granted Jul 29, 2008·6 cites·9 claims
- 1469US2025074875A1At2r antagonists and uses thereofLILLY CO ELI·Filed 2024·Application pending·0 cites
- 1567US12122750B2AT2R antagonists and uses thereofLILLY CO ELI·Filed 2023·Granted Oct 22, 2024·0 cites·28 claims
- 1666US8076374B2Glucagon receptor antagonists, preparation and therapeutic usesCHAPPELL MARK DONALD·Filed 2006·Granted Dec 13, 2011·1 cites·10 claims
- 1765US8084489B2Glucagon receptor antagonists, preparation and therapeutic usesCHAPPELL MARK DONALD·Filed 2006·Granted Dec 27, 2011·1 cites·7 claims
- 1864US7528160B2Fused heterocyclic derivatives as PPAR modulatorsLILLY CO ELI·Filed 2003·Granted May 5, 2009·2 cites·13 claims
- 1960US2024246979A1cGAS INHIBITORSLILLY CO ELI·Filed 2023·Application pending·0 cites
- 2059US2008146631A1Oxazolyl-aryloxyacetic acid derivatives and their use as ppar agonistsBROOKS DAWN ALISA·Filed 2008·Application pending·0 cites
- 2158US2023391786A1cGAS INHIBITORSLILLY CO ELI·Filed 2023·Application pending·0 cites
- 2252US7396850B2Pyrazole derivative as PPAR modulatorLILLY CO ELI·Filed 2003·Granted Jul 8, 2008·0 cites·9 claims
- 2348US2010324140A1Glucagon receptor antagonists, preparation and therapeutic usesLILLY CO ELI·Filed 2010·Application pending·0 cites
- 2445US8691856B2Glucagon receptor antagonists, preparation and therapeutic usesCONNER SCOTT EUGENE·Filed 2006·Granted Apr 8, 2014·0 cites·10 claims
- 2545US7807702B2Substituted thiophene carboxylic amide glucagon receptor antagonists, preparation and therapeutic usesLILLY CO ELI·Filed 2006·Granted Oct 5, 2010·0 cites·8 claims
- 2644US8609892B2Glucagon receptor antagonists, preparation and therapeutic usesCONNER SCOTT EUGENE·Filed 2011·Granted Dec 17, 2013·0 cites·18 claims
- 2742US2006166983A1Indole derivatives as ppar modulatorsLILLY CO ELI·Filed 2003·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Scott Eugene Conner files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →